Skip to content

Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults

Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation for Personalized Neurofeedback

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05592600
Enrollment
24
Registered
2022-10-24
Start date
2023-10-06
Completion date
2025-02-24
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Healthy adult subjects will participate in two sessions. The first session will involve measurements of brain activity using simultaneous recordings with electroencephalography (EEG) and functional Magnetic Resonance Imaging (fMRI). During brain activity measurement, participants will perform cognitive tasks assessing attention. The second will involve fMRI-based neurofeedback during simultaneous EEG-fMRI recording. Participants will receive real-time visual feedback of signals measured from specific parts of their brain and will try to control that activity.

Detailed description

Neuropsychiatric conditions are increasingly being understood as disorders of intrinsic, functional interactions within and between widespread, distributed, brain networks. Given recent advances in functional Magnetic Resonance Imaging (fMRI) data acquisition and computational analysis, it is now possible to reliably map the functional neuroanatomy of brain networks within individuals, offering a potential avenue for identifying personalized neurotherapeutic targets. However, gold standard treatments (e.g. pharmacotherapy) in current psychiatric practice were not originally designed to target specific brain network interactions and lack protocols that leverage such individual-level data. Real-time neurofeedback- whereby patients observe and learn to regulate selected aspects of their own brain activity- is a candidate approach to personally tailor the normalization of unhealthy communication within and between brain networks. However, to target the major brain networks that function abnormally in neuropsychiatric conditions, neurofeedback relies on fMRI, which is an expensive procedure involving a complex setup and patient burden. The goal of this project is to develop an electroencephalography (EEG) "fingerprint" of fMRI network dynamics so that a neurofeedback system based on EEG (electrodes placed on the scalp) alone can be used to precisely target interactions within and between brain networks. Because EEG devices can be portable and offer relatively simple setup in flexible settings, this research could enable a scalable form of network-based neurofeedback training that patients could regularly access. Aim 1 of this research is identify an optimal model of EEG features that are predictive of fMRI-based default mode network (DMN) "antagonism" within individuals. The investigators focus on this DMN antagonism because it is a major feature that is relevant to cognitive dysfunction in psychiatry disease at a transdiagnostic level. The investigators will collect high-quality, simultaneous EEG-fMRI data in 24 healthy adults (\>100 mins of sampling per participant), including three conditions: (1) resting state, (2) continuous task performance, and (3) continuous fMRI-based neurofeedback from DMN antagonism states. The investigators will apply machine learning-based methods to identify an optimal mapping between EEG signal components and fMRI-based DMN antagonism. Further, the investigators will determine how much individual-level EEG-fMRI sampling is needed to successfully predict DMN antagonism from EEG. Aim 2 of the research is to test whether EEG markers of DMN antagonism are predictive of cognitive task performance fluctuations within individuals. As such, the findings could offer validation of the behavioral relevance of an EEG neurofeedback system that would target DMN antagonism. If successful, the work can lead to development of an accessible, computational psychiatry tool that can be tested in clinical conditions in which DMN antagonism (and related cognitive function) is affected, including attention-deficit/hyperactivity disorder, depression and schizophrenia.

Interventions

BEHAVIORALNeurofeedback

Participants will visualize real-time feedback of signals recorded from their brains as measured with functional MRI.

Sponsors

Drexel University
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18-35

Exclusion criteria

* History of psychiatric or neurological disorder * contraindication for MRI

Design outcomes

Primary

MeasureTime frameDescription
Association Between EEG Measurements and Default Mode Network Brain Activity Measured With fMRITwo sessions 3 to 62 daysThe investigators determined the degree to which features within EEG signals can approximate fMRI (default mode network activation) while participants performed cognitive tasks and brain activity was recorded with simultaneous EEG-fMRI. Model predictions (EEG prediction of fMRI) within each participant were generated from multiple EEG features, including spectral power in different frequency bands (Theta: 4-7 Hz, Alpha: 8-12 Hz, Beta1: 13-22 Hz, Beta2: 23-29 Hz, Gamma: 30-50 Hz). The average temporal correlation across the two sessions was computed between EEG and fMRI. A higher correlation indicated that EEG was more predictive of fMRI, whereas a lower correlation indicated EEG was less predictive of fMRI.

Countries

United States

Participant flow

Pre-assignment details

Potential participants were excluded from the study if they were unable to provide consent, reported having a current or history of psychiatric/neurological disorders, a chronic medical condition, were pregnant, were prisoners, were unable to understand English, had metal in the body, were contraindicated for MRI, had allergies to saline gel, or had cold, flu or COVID-19 symptoms within the two weeks preceding participation.

Baseline characteristics

Characteristic
Age, Continuous21.17 Years
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
4 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
14 Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 24
other
Total, other adverse events
0 / 24
serious
Total, serious adverse events
0 / 24

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026